ERVW-1 and infection: Following infection by a transmitter founder (T/F) virus, a humoral response is rapidly established with mostly non-neutralizing antibodies (Abs) being directed against HIV-1 envelope glycoproteins (Env, gp120 and gp41) [1,2,3].